U.S. Patent Disclosures
Clarus Therapeutics Inc., of Northbrook, Ill., was issued U.S. Patent No. 8,241,664, "Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same," related to its testosterone product, CLR-610.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.